Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Imaging CAR T-cell kinetics in solid tumors: Translational implications

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.06.006Source: DataRank Database

Imaging CAR T-cell kinetics in solid tumors: Translational implications is a research paper published in Molecular Therapy — Oncolytics (2021). On theSindex it has a DataRank of 1.6. It has been cited 49 times, with 47 citing works in its 1-hop citation network.

N/A

1.6DataRank · unranked

Scored on demand from live citation data

Open Access49 citations · 47 citing works in its network

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 2.03)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 36%Citation Network 64%

Base Score Contribution

0.587

From this paper's citation signal

Citation Network Contribution

1.0

From 36 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 47 citers.

Switchable CAR T cell strategy against osteosarcoma
Cancer Immunology Immunotherapy202328 citations30 referencesContributes 0.112
Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial
Lung Cancer202232 citations47 referencesContributes 0.074
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC
Frontiers in Immunology202412 citations36 referencesContributes 0.071
Editorial: Enhancing CAR T-cell therapy with imaging
Frontiers in Immunology20251 citations10 referencesContributes 0.069
CAR T cells for solid tumors – developments to watch in 2023
Expert Opinion on Biological Therapy20243 citations22 referencesContributes 0.063

Authors (10)

Hocine R. Hocine ORCID,Jasmeen Saini ORCID,Maxim A. Moroz,Rebecca Y. Bellis ORCID,Srijita Banerjee

Live enrichment

PubMed:34553024 PMC:PMC8426175 OpenAlex:https://openalex.org/W3172374112

National Institutes of Health

Grant: P30 CA008748

National Institutes of Health

Grant: R01 CA235667

National Institutes of Health

Grant: R01 CA236615-01

National Institutes of Health

Grant: T32CA009501

U.S. Department of Defense

Grant: BC132124

U.S. Department of Defense

Grant: CA170630

U.S. Department of Defense

Grant: CA180889

U.S. Department of Defense

Grant: LC160212

NCI NIH HHS

Grant: P50 CA092629

NCI NIH HHS

Grant: R01 CA163980

NCI NIH HHS

Grant: R01 CA220524

National Institutes of Health

Grant: 5T32CA009501-22

SURGICAL ONCOLOGY RESEARCH TRAINING GRANT

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5R01CA236615-02

Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors

National Institutes of Health

Grant: 5R01CA235667-02

A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma

Atara Biotherapeutics

Geoffrey Beene Cancer Research Center

Derfner Foundation

FWCI

2.03

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttp://www.cell.com/article/S2372770521000851/pdf

publisherhttp://www.cell.com/article/S2372770521000851/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2372770521000851?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2372770521000851?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omto.2021.06.006

Fields of Study

CAR-T cell therapy researchImmunotherapy and Immune ResponsesViral Infectious Diseases and Gene Expression in Insects0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

KineticsPhysicsClassical mechanicsGene therapyLung cancerImmunotherapyCell therapyMesotheliomaPet-ctIn vivo ImagingCar T cellsImaging ReporterImmunotherapy KineticsNoninvasive Immunotherapy ImagingNeoplasms. Tumors. Oncology. Including cancer and carcinogensOriginal ArticleRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being